Tilray (NASDAQ:TLRY) Stock Price Up 5.4%

Tilray Inc (NASDAQ:TLRYGet Free Report)’s stock price was up 5.4% during trading on Wednesday . The stock traded as high as $2.56 and last traded at $2.54. Approximately 15,127,146 shares traded hands during trading, a decline of 42% from the average daily volume of 26,024,230 shares. The stock had previously closed at $2.41.

Tilray Price Performance

The company has a current ratio of 1.63, a quick ratio of 0.99 and a debt-to-equity ratio of 0.11. The firm has a market cap of $2.12 billion, a PE ratio of -1.14 and a beta of 2.36. The company has a 50 day moving average price of $1.91 and a 200 day moving average price of $1.98.

Insider Buying and Selling

In other Tilray news, CEO Irwin D. Simon purchased 53,700 shares of the business’s stock in a transaction on Friday, January 12th. The stock was bought at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the acquisition, the chief executive officer now owns 2,033,058 shares of the company’s stock, valued at approximately $3,822,149.04. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Irwin D. Simon acquired 53,700 shares of the stock in a transaction dated Friday, January 12th. The stock was bought at an average cost of $1.88 per share, with a total value of $100,956.00. Following the purchase, the chief executive officer now directly owns 2,033,058 shares of the company’s stock, valued at $3,822,149.04. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Carl A. Merton acquired 20,000 shares of the stock in a transaction dated Friday, January 12th. The shares were bought at an average cost of $1.87 per share, with a total value of $37,400.00. Following the completion of the purchase, the chief financial officer now directly owns 20,000 shares in the company, valued at $37,400. The disclosure for this purchase can be found here. Insiders purchased 96,300 shares of company stock worth $183,210 in the last ninety days. Insiders own 0.68% of the company’s stock.

Institutional Trading of Tilray

A number of institutional investors have recently added to or reduced their stakes in TLRY. Hudson Bay Capital Management LP boosted its position in Tilray by 29.4% during the 3rd quarter. Hudson Bay Capital Management LP now owns 16,181,157 shares of the company’s stock worth $38,673,000 after purchasing an additional 3,681,157 shares during the period. Marshall Wace LLP purchased a new stake in Tilray during the 4th quarter worth $6,586,000. Gotham Asset Management LLC boosted its position in Tilray by 1,038.7% during the 3rd quarter. Gotham Asset Management LLC now owns 1,168,774 shares of the company’s stock worth $2,793,000 after purchasing an additional 1,066,137 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Tilray during the 3rd quarter worth $2,023,000. Finally, Thrivent Financial for Lutherans purchased a new stake in Tilray during the 2nd quarter worth $2,212,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Tilray

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Recommended Stories

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.